MediciNova: Q3 Earnings Snapshot
LA JOLLA, Calif. (AP) — LA JOLLA, Calif. (AP) — MediciNova Inc. (MNOV) on Wednesday reported a loss of $2.9 million in its third quarter. On a per-share basis, the La Jolla, California-based company said it had a loss of 6 cents. This story was ...
Phoenix New Media: Q3 Earnings Snapshot
For the current quarter ending in December, Phoenix New Media said it expects revenue in the range of $28.2 million to $30.3 million. This story was generated by Automated Insights ( using data from Zacks Investment Research.
TherapeuticsMD: Q3 Earnings Snapshot
TherapeuticsMD: Q3 Earnings Snapshot
Harrow: Q3 Earnings Snapshot
Harrow, Inc. (HROW) on
Cosan: Q3 Earnings Snapshot
SAO PAULO SP, Brazil (AP) — SAO PAULO SP, Brazil (AP) — Cosan S.A. (CSAN) on Wednesday reported net income of $52.8 million in its third quarter. On a per-share basis, the Sao Paulo Sp, Brazil-based company said it had net income of 11 cents. Earnings, adjusted to account for discontinued operations, came to 10 cents per share. The bioethanol company posted revenue of $2.1 billion in the period.
Afya: Q3 Earnings Snapshot
(AFYA) on Wednesday reported third-quarter earnings of $21.6 million. On a per-share basis, the Nova Lima, Brazil-based company said it had profit of 24 cents. Earnings, adjusted for amortization costs and non-recurring costs,
Oragenics: Q3 Earnings Snapshot
Oragenics Inc. (OGEN) on
MediciNova Given Notice of Monetary Damages Due Under Patent Settlement of Sanofi-Novartis
Yuichi Iwaki, M.D., Ph.D., MediciNova CEO commented, “The successful resolution of the Sanofi-Novartis litigation and the resulting monetary damages due to MediciNova both validates the value of our ...
Eagle-Tribune22d
MediciNova Announces Update of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS patients ...
LA JOLLA, Calif., Oct. 23, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock ...
Yahoo Finance1mon
MediciNova (NASDAQ:MNOV) shareholders have endured a 73% loss from investing in the stock five years ago
It is doubtless a positive to see that the MediciNova, Inc. (NASDAQ:MNOV) share price has gained some 45% in the last three months. But will that heal all the wounds inflicted over 5 years of ...
MediciNova notified of settlement in Sanofi Novartis litigation
MediciNova (MNOV) was notified by Sanofi (SNY) that the Sanofi/Novartis (NVS) litigation was settled. Accordingly, MediciNova is entitled to ...
ETF Daily News7d
MediciNova (NASDAQ:MNOV) Share Price Crosses Above 200 Day Moving Average – Here’s Why
MediciNova, Inc. (NASDAQ:MNOV – Get Free Report) shares crossed above its 200-day moving average during trading on Wednesday .The stock has a 200-day moving average of $1.50 and traded as high ...
CNN1y
MediciNova, Inc.
MediciNova, Inc. is a biopharmaceutical company, which engages in the acquisition and development of small molecule therapeutics for the treatment of diseases with unmet medical needs. The company ...
Finanznachrichten1y
MediciNova, Inc.: MediciNova Given Notice of Monetary Damages Due Under Patent Settlement of Sanofi-Novartis
LA JOLLA, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock ...
MediciNova (NASDAQ:MNOV) Coverage Initiated by Analysts at StockNews.com
StockNews.com assumed coverage on shares of MediciNova (NASDAQ:MNOV – Free Report) in a report released on Wednesday. The firm issued a hold rating on the biopharmaceutical company’s stock. MediciNova ...
Yahoo Finance1mon
MediciNova, Inc. (MNOV)
LA JOLLA, Calif., Sept. 09, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock ...